Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Implantica publishes Interim Report Q3, January-September 2020 | ||||||
By: PR Newswire Association LLC. - 18 Nov 2020 | Back to overview list |
|||||
STOCKHOLM , Nov. 18, 2020 /PRNewswire/ -- "It is with great pleasure that we provide our first quarterly report since listing on Sweden's Nasdaq First North Premier Growth Market on 21 September." - Peter Forsell, CEO and Founder of Implantica AG Significant events during the third quarter, 2020
Significant events after the end of the reporting period
July - September 2020
January - September 2020
Implantica will hold a telephone conference on November 18 at 10:30 CET To participate, please dial: For further information, please contact: Nicole Pehrsson, Investor Relations Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, +46 (0)8 528 00 399, info@fnca.se The information was sent for publication, through the agency of the contact person set out above, on November 18, 2020 at 08:00 a.m. CET. About Implantica Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information. This information was brought to you by Cision http://news.cision.com The following files are available for download:
|
||||||
|
||||||
Copyright 2020 PR Newswire Association LLC. | Back to overview list |